CLOs on the Move

Motif Neurotech

www.motifneuro.tech

 
Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Noctrix Health

Noctrix Health is a pioneer in developing the next-generation of wearable therapeutics. Backed by scientific evidence and clinical data, we aim to make prescription-grade medical devices accessible so physicians and patients have more choices beyond the pill. Stay tuned for updates.

GT Urological

GT Urological is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Kirwan Surgical Products Inc

Kirwan Surgical Products Inc is a Marshfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sinclair Pharmaceuticals

Sinclair Pharmaceuticals, Ltd. is a Carrollton, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Medacta USA

Medacta International is a Swiss company developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. Founded in 1999 with a vision to create a better patient experience for people needing joint and spine treatment, Medacta specializes in highly innovative minimally-invasive, personalized approaches designed to bring renewed hope and optimism to patients. Medacta is a recognized leader in Hip Replacement with its proprietary AMIS® (Anterior Minimally Invasive Surgery) product offerings and in Knee Replacement via MyKnee® Patient Matched 3-D printing technology. At the 2014 North American Spine Society (NASS) Annual Meeting, Medacta`s new MySpine® Patient Matched product was awarded "Best New Technology - Posterior Thoracolumbar Spine Treatments".